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 
Abstract— Goal: In a pivotal clinical trial, the percutaneous 
catheter-based renal denervation system developed to treat 
resistant hypertension did not show effectiveness in reducing 
blood pressure because of its fundamental limitation to ablate 
deeper nerves present around the renal artery. Methods: We 
propose a new renal denervation strategy called laparoscopic 
denervation system (LDS) based-on laparoscopy procedure to 
ablate the renal nerves completely but inhibit the thermal arterial 
damage. The system has flexible electrodes to bend around the 
arterial wall to ablate nerves The simulation study using validated 
in-silico models evaluated the heat distribution on the outer 
arterial wall, and an acute animal study (swine model) was 
conducted to demonstrate the feasibility of LDS in vivo. Results: 
The simulation study confirmed that LDS could localize the heat 
distribution between the electrode and the outer arterial wall. In 
the animal study, we could maximize nerve denervation by the 
localizing ablation energy within the renal nerves and achieve 
nerve denaturation and decrease in neural density by 20.78 % 
(P<0.001), while maintaining a constant tip temperature of 65 ℃ 
for the duration of 70 s treatment. The study confirmed intact 
lumen artery through histological analysis and acute reduction in 
systolic blood pressure by 9.55 mmHg (p<0.001) Conclusion: The 
LDS presented here has potential to effectively and safely ablate 
the renal nerves, independent of anatomical variation and nerve 
distribution, to control hypertension in real clinical conditions. 
Significance: LDS approach is innovative, inventive, and presents 
a novel technique to treat hypertension.  
 
Index Terms—Hypertension, denervation, animals, 
laparoscopy, radiofrequency ablation, finite element modeling   
I. INTRODUCTION 
ypertension is the most common disease in humankind 
with a current global prevalence of about 1.39 billion, 
which accounts for 31.1% of the adult population and is 
expected to keep increasing [1, 2]. Despite hypertension being 
the leading global disease burden, ironically, it is also the 
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leading preventable risk factor of death and disability 
worldwide [3]. Many antihypertensive drugs have been 
developed over decades and available in the market. However, 
a large proportion of patients’ blood pressure still remains 
uncontrolled because of resistant hypertension [4]. Resistant 
hypertension is defined as a disease in which blood pressure 
(BP) cannot be controlled despite the concurrent use of 3 or 
more antihypertensive drug combinations [5]. One pooled 
analysis estimated that the prevalence of this life-threatening 
resistant hypertension is 10.1% of adults being treated for 
hypertension [6].  
The hyperactivity of the renal sympathetic nerve is known to 
be an important pathogenesis of essential and resistant 
hypertension [7]. In the early 60s, sympathectomy, which 
surgically destroys the thoracic and lumbar sympathetic 
ganglia, was introduced to control the sympathetic nerve and 
thus to treat resistant hypertension [8]. This method clearly 
showed a postoperative decrease in BP and survival benefits [8, 
9]. However, due to the severe invasiveness and morbidity 
associated with the surgical procedure, this method was 
abandoned from the practice [10]. Then, percutaneous catheter-
based renal denervation (RDN) has been recently proposed as 
an alternative for treating resistant hypertension with reduced 
invasiveness [11, 12]. This concept initially gained large 
traction due to its minimal invasiveness and promising initial 
data [11, 13]. However, a recently conducted phase III 
randomized controlled trial showed that this approach showed 
no effectiveness in BP reduction when compared to sham 
control [14]. The failure of catheter-based RDN can be 
attributed due to many reasons as outlined in [15]. 
While it cannot be generalized, the lesion depth for the 
catheter-based RDN was found to be about 2 mm for a cadaver 
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[16] and 6 mm for animal models [17-19] from multiple studies, 
but 31% of renal nerves are located 2-10 mm away from the 
endoluminal surface [20, 21]. Thus, it cannot completely ablate 
renal sympathetic nerves outside the arterial wall. Increasing 
the ablation energy to reach beyond 2 mm would cause 
irreversible intima injury resulting in serious complications 
such as atherosclerosis, thrombosis, or stenosis [22, 23]. 
Furthermore, the catheter denervation is only applicable to the 
renal artery with a diameter ≥ 3mm. However, small arteries, 
such as accessory arteries or early branched arteries, also have 
nerves that still have a significant effect on controlling BP [24, 
25]. Also, the catheter-based modality requires expertise to 
guide the catheter from aorta to the main renal artery [15].  
Thus a procedure to effectively ablate renal nerves while not 
being as invasive as sympathectomy is needed to treat the 
resistant hypertension patients. The system should also be safe, 
operator-independent, and achieve complete denervation. As 
explained in our previous simulation study, our hypothesis was 
that the solution to satisfy these unmet needs could be found in 
a laparoscopic approach [17]. The laparoscopic RDN provides 
more effective denervation compared to the catheter-based 
RDN and is independent of anatomical variation in the renal 
artery and nerve distribution. It also achieves the denervation 
without injuring the artery [17] and its adjacent organs. Even 
though the proposed laparoscopy-based technique is more 
invasive compared to catheter-based RDN, it enhances the 
safety against thermal damage to the artery and the nerve 
denervation is more effective than the catheter-based approach.  
In this paper, we present a novel laparoscopic denervation 
system (LDS) and provide surgical guidelines for applying 
laparoscopic RDN in clinical trials. The system is composed of 
a laparoscopic instrument with a round-shaped flexible 
electrode and an automatic ablation temperature control system. 
In the next few sections, we will present details of the LDS 
system along with the simulation and validation experiment. 
Next, we will utilize in-vivo simulation and cumulative 
equivalent minutes at 43℃ (CEM43) to guide first-time in-vivo 
study using LDS. Finally, we will demonstrate the feasibility of 
LDS in animal studies using a swine model and conclude with 
a discussion. 
II. LAPAROSCOPIC DENERVATION SYSTEM  
Fig. 1a shows our proposed laparoscopic RDN system, and 
the procedure is illustrated in Fig. 1b. If the procedure is 
conducted through the posterior retroperitoneal approach, as 
shown in Fig. 2, it provides direct access to the renal arteries 
without affecting intraperitoneal organs. This approach presents 
a significant advantage compared to the transperitoneal 
approach, where the laparoscopic trocar punctures the 
peritoneum and passes through the intraperitoneal organs 
before accessing the retroperitoneal space. After a patient is 
positioned in the modified prone position like Fig. 1a, the 
procedure followed is as follows: (1) dissect between psoas 
muscle and kidney to access renal hilum; (2) remove fat tissues 
around the renal hilum of kidney, and identify connective 
tissues and renal sympathetic nerves surrounding the renal 
 
Fig. 1.  Laparoscopic renal denervation. (a) The modified prone position for the laparoscopic RDN. (b) Schematic to show the steps of laparoscopic RDN; b1, 
Dissection between Psoas muscle and Gerota’s fascia; b2, Removal of fat tissues around the renal hilum and identification of connective tissues surrounding the 
renal artery including renal sympathetic nerves; b3, Removal of peri-arterial connective tissue using a laparoscopic monopolar hook electrode; b4, Securing space 









Renal artery and surrounding 





Fig. 2. Retroperitoneal approach (red) and transperitoneal approach (blue) 
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artery; (3) remove the peri-arterial connective tissue 
meticulously using a laparoscopic instrument such as 
monopolar hook electrode; (4) secure the space to insert the 
laparoscopic ablation instrument; and (5) insert the instrument 
through a 5mm working port to ablate renal sympathetic nerves 
around the renal artery by wrapping it 360 degrees. During the 
4th step, make sure all surrounding tissue between the renal 
artery and renal vein is secured. If the patient has an additional 
artery or early branch, repeat the procedure (2) through (5).  
The retroperitoneal surgical space is limited, and target 
nerves are randomly distributed around various size arteries. 
Thus, the three main requirements of laparoscopic instrument 
design for RDN are: (1) should be able to automatically wrap 
both renal artery and nerves for effective denervation regardless 
of the nerve distribution, (2) should prevent thermal damage to 
tunica intima by concentrating heat between the instrument tip 
and the outer wall of the artery, and (3) should be available in 
various sizes to cover main artery, accessory artery, and early-
branching artery.  
A. Bipolar flexible electrode 
The prototype of our ablation instrument meeting all three 
requirements is shown in Fig. 3a. It is composed of two parts; 
electrical ablation tip and mechanical actuator. The electrical 
ablation tip, as shown in Fig. 3c contains a biocompatible heat-
treated stainless steel (SUS) plate that changes shape from 
straight to round when extruded from tip head, and it maintains 
its round shape without external load. The SUS plate is coated 
with a flexible printed circuit board (FPCB), where parallel 
copper-coated-gold electrodes are attached over polyimide film. 
The parallel electrodes form bipolar configuration localizing 
electrical current path between the electrodes, and the 
concentration results in heat generation at tissue. This 
configuration confines the heat between the electrode surface 
and the outer wall of the artery. 
The actuator part includes a rack, pinion gear, and a four lead 
screw. The rack and pinion gear facilitate the surgical operation 
to bind the renal artery, as shown in Fig. 3a, by simple back and 
forth manipulation of the gear without needing manual handling. 
The four lead screws adjust the tip diameter from 7 mm to 2 
mm, as shown in Fig 3b, and controls the guide to tighten the 
ablation tip for tight contact with various sizes of renal arteries. 
Furthermore, we performed repeatability testing of tip bending 
and the unrolling process. Even after twenty or more repeated 
processes during lab testing and preclinical study, the ablation 
tip preserved round shape to successfully cover the renal artery 
and nerves.  
B. Automatic ablation temperature control system  
To minimize forming thermal lesion during denervation and 
to prevent damaging tunica intima, we use temperature-
controlled radiofrequency (RF) ablation [26]. In temperature-
controlled ablation, the temperature is maintained constant 
through the procedure. We use an automatic ablation 
temperature control system, as shown in Fig. 4, to control the 
temperature. It consists of a function generator (AFG3101, 
Tektronix), an RF power amplifier (LZY-22+, Mini-circuits), 
two bi-directional couplers (ZABDC50-150HP+, Mini-
circuits), two power sensors (U2004A, Keysight 
Technologies), a vector network analyzer (E5061B, Keysight 
Technologies), a three single pole double throw type of RF 
switch (USB-4SPDT-A18, Mini-circuits), an analog-to-digital 
converter (DAQ, NI9213, National Instruments), and a 
computer controller (LabVIEW, National Instruments). The 
controller simultaneously controls the function generator, RF 
switch, VNA, power sensors, and DAQ and also monitors: (1) 
tip temperature, (2) transmitted and reflected RF power at 
power sensors connected to directional couplers, and (3) 
impedance between parallel electrodes at VNA with frequency 
varying from 1 kHz to 10MHz.  
Before the treatment begins, the system sets the input RF 
power level taking into consideration the reflected power 
caused by the impedance mismatch between the system output 
 
Fig. 3.  Designs and materials for the ablation instrument. (a) A minimally invasive laparoscopic ablation instrument. (b) Flexible tip diameter is changed from 7 
mm to 2 mm to cover various sizes of arteries. (c) Laminated tip stacked with laminations in the following order from the bottom: polyimide film, SUS plate, 
thermocouple probe, polyimide, and bipolar electrode. 
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Fig. 4. The configuration of automatic ablation temperature control system. 
The system measures tip temperature, load impedance, incident power Pinc, 
reflected power Pref, and transmitted power Ptr.  
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and the ablation instrument. During treatment, the function 
generator delivered 1 MHz RF signal and amplified RF power 
to heat the ablation tip. The power is modulated by changing 
the RF switching time with the pulse-width-modulation (PWM) 
method to maintain a constant tip temperature. The RF switch 
connects the ablation instrument to the amplified RF power in 
the “On state” of the PWM and the VNA in the “Off state” of 
the PWM. A feedback control system decides the period and 
duty cycle of the PWM by comparing the monitored tip 
temperature with pre-set tip temperature. 
III. FINITE ELEMENT METHOD MODELING  
To achieve complete RDN while preventing damage to arterial 
wall and vein, we analyzed temperature distribution during 
denervation with thermoelectrical finite element modeling 
(FEM) using ANSYS Fluent. The peak temperature and 
duration of ablation determined by the simulation study are 
used to control RF ablation during the animal study.  
The Bio-heat equation is the governing equation to obtain 
thermal distribution in tissue. The equation below describes the 




= ∇ ∙ 𝑘∇𝑇 + 𝑞 − 𝑄𝑐𝑜𝑜𝑙𝑖𝑛𝑔 + 𝑄𝑚𝑒𝑡𝑎  (1) 
where T is temperature, t is time, and other parameters are 
thermal properties: thermal conductivity of tissue k, the specific 
heat of tissue c, and mass density of tissue ρ; electrical 
properties: heat source from electrical energy q; and 
temperature cooling effect caused by blood or airflow 𝑄𝑐𝑜𝑜𝑙𝑖𝑛𝑔. 
In this simulation study, we ignored the metabolic heat 𝑄𝑚𝑒𝑡𝑎 
since it is negligible compared to others [27]. 
With respect to the electric problem, the 1 MHz wavelength of 
the signal used in LDS is more than the size of the flexible 
electrode wrapping the renal artery and nerves. Therefore a 
quasi-static approximation was applied to solve the electric 
fields in the renal artery and nerves [29]. A governing equation 
used to solve electrical potential in tissue is given by: 
∇ ∙ σ∇V = 0 (2) 
where σ is the electrical conductivity of tissue, and V is 
electrical potential. The electric field is the gradient of electrical 
potential.  
E = −∇V (3) 
The heat source term q was calculated using Ohm’s law. 
q = J ∙ E = σ(∇V)2 (4) 
The electrical conductivity of tissue is temperature-dependent 
and is as given by: 
σ(T) = σ0(1 + 𝑘∆𝑇) (5) 
where σ  is electrical conductivity, σ0  is reference electrical 
conductivity at 25℃, k is the temperature constant, and ∆𝑇 is 
the temperature difference from 25℃. We set the temperature 
constant at 2%℃−1 . A convection effect was applied at the 
outer arterial wall as a boundary condition: 
Qair = ℎ(𝑇 − 𝑇0) (6) 
We assumed free convection at walls exposed to CO2 gas with 
convective heat transfer coefficient (h) of 25 Wm-2K-1 and free 
stream temperature (𝑇0)  of 300 K. In laparoscopic renal 
denervation, due to the detachment of target renal artery from 
fat, periarterial connective tissue and capillaries, the blood 
perfusion in the artery will be decreased. In addition, the 
cooling effect by bulk blood flow in this detached artery is more 
dominant than blood perfusion [30]. Therefore, we used fluid 
flow to simulate blood cooling effect and not blood perfusion 
in the lumen of the artery. Blood cooling effect (Qblood) was 
simulated using a velocity inlet (blood flow rate) and a static 
pressure outlet as 0 Pa. In ANSYS Fluent, the Bio-heat equation 
was coded and applied to model via a built-in user-defined 
function. Using the user-defined scalar and the specified value 
at both electrodes, with zero specified flux at the other parts, we 
simulated the transient situation with 1 second time step size 
and 90-time steps in in vitro stimulation and the steady-state 
situation in vivo simulation. In the animal study, the ablation tip 
temperature remained constant due to the automatic ablation 
temperature control system. 
In vitro simulation, the phantom gel surrounds the ablation tip, 
guide, and tip head. The material’s density, specific heat, 
electrical conductivity, and thermal conductivity of each 
material are illustrated in Table I [28, 31-35]. In phantom, we 
measured electrical conductivity by an impedance analyzer 
TABLE I 







(𝐽/𝑘𝑔 ∙ 𝐾) 
thermal 
conductivity  








**Blood b, c 1060 3890 0.531 0.67 
Tunica adventitia b 1027 2372 0.39 0.392 
Tunica media b, d  1050 3314 0.450 0.33 
SUS304 e 8000 500 16.2 1.39 x 106 
Polyimide 1420 1090 0.12 6.6 x 10−16 
*Sensitivity analysis: 0.48, 0.49, 0.50 
**Blood flow rate: 0.28, 0.48, 0.68 (m/s) 
aPark, bDuck, cGolombeck, dEdgerton, eChen 
 
Fig. 5.  (a) Configuration of modeled laparoscopic renal denervation and (b) 
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(E4990A, Keysight Technologies) with a liquid test fixture 
(16452A, Keysight Technologies), calculated material’s 
density, and considered the specific heat of the gel as the value 
of water. We also performed sensitivity analyses to test the 
effect of temperature dependency as the thermal conductivity 
of the phantom was varied from 0.48 to 0.5 in the temperature 
range 37-97 ℃ [36].  
After establishing the validity of using the meshing method, 
bio-heat equation, and setting boundary conditions in vitro, we 
extended these techniques to in-vivo simulation with the renal 
artery model. In in-vivo simulation, the artery 3D, as shown in 
Fig. 5 was designed based on previous histological studies 
where the diameter of the artery, the diameter of the lumen, and 
thickness of the artery wall were 5 mm, 2mm, and 1.5 mm, 
respectively [17, 21]. The arterial wall was composed of tunica 
media and adventitia. To analyze heat distribution in various in-
vivo studies, we changed the ratio of the thickness of the tunica 
media and adventitia while maintaining the total diameter of the 
artery as 5 mm. Compared to the phantom gel in in-vitro 
modeling, in in vivo arterial blood flow was taken into account 
with the flow rates from 0.28 to 0.68 m/s [37]. The blood 
temperature was set as 310 K with other conditions remaining 
the same. At electrode-tissue interfaces, the electric potential of 
an electrode in Fig. 3c was zero. The electric potential of the 
other electrode was chosen to make the temperature between 
the two electrodes at 60 or 65 ℃ in the steady-state condition. 
The modeling domain was a cuboid with 30 mm (height) x 20 
mm (length) x 20 mm (width) in the phantom simulation. The 
artery was of the cylinder in shape with a height of 20 mm and 
a radius of 2.5 mm in vivo simulation. The default element size 
was 0.1 mm, and the element size near the electrodes was 0.05 
mm. 
IV. VALIDATION OF THE MODEL 
Fig. 6b shows the validation experiment setup and applied 1 
W RF energy to the instrument for 90 seconds. The phantom 
was manufactured by mixing 6 L water with 48 g gelling agent 
(polyacrylic acid solution, Sigma-Aldrich) in a 160 
mm×430mm×170mm acrylic water tank. In this phantom gel, 
we considered that the convection effect was almost zero, mass 
density and specific heat were the same with water. The 
electrical conductivity of the phantom was measured using an 
impedance analyzer (E4990A, Keysight Technologies).  
We used fiber optic temperature probes (STB Probe, Luxtron 
Corporation) combined with data acquisitions (system M604, 
Luxtron Corporation) to measure the temperature distribution. 
The probes measured temperature at the tip of the probe using 
light and set up minimizes the electromagnetic interference. 
The temperature probes were fixed to two types of 3D printed 
fixtures (Project MJP 2500, 3D Systems). Fig. 6b shows two 
types of fixtures. The sides of a hexagon in one fixture was 1 
mm and the second fixture was 2 mm. The fixtures have 7 
temperature probe holders with one each at 6 vertices and one 
at the center of the hexagon. A fixture was anchored to a 3-axis 
stage, tuned for the 7 probes located at a side of electrode (x=0 
or 6 mm plane), and coordinated with the center of the flexible 
electrode. Next, the fixture moved 0.5 mm from one side of the 
electrode to the other side, whose width was 6 mm. The 
measurements were repeated with the other fixture. There were 
13 temperature measurement points in a plane, as shown in Fig. 
6a and total points were 169 ((6+6+1)×13), where we assumed 
the center of two fixtures being the same. 
The temperature at the location of the thermocouple probe and 
169 points corresponding to the position of fiber optic 
temperature probes were post-processed. For facilitating 
comparison between modeling and experimental data, the 
temperature at point i (1≤i≤169, where i is an integer) was 
normalized using the formula: 








where NTexp𝑖  is the experimental normalized temperature at 
point i, 𝑇exp𝑖  is the experimental temperature (K) measured at 
point i, and 𝑇exp𝑐 is the experimental temperature (K) at 
thermocouple. 𝑇exp𝑖 was standardized with 𝑇exp𝑐  because 
inserted thermocouple between FPCB and SUS plate and its 
position remained unchanged. The 300 (K) was subtracted from 
𝑇exp𝑖 and 𝑇exp𝑐  considering the initial room temperature. 
NTFEM𝑖  is described using Eq. (8) in the similar manner. 
Relative error between NTexp𝑖  and NTFEM𝑖  was calculated by: 
 
Fig. 6.  The experiment of parameter-controlling phantom gel. (a) Geometry of the FEM model (13 temperature measurement points and a thermocouple probe) 
(b) Experimental setup of RF heating using the flexible electrode; b1, Temperature measurement points are 0 and 7–12; b2, Temperature measurement points are 
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Relative Error (%) = |
NTexp𝑖  − NTFEM𝑖  
NTexp𝑖  
| × 100 (9) 
V. ANIMAL STUDY  
A. Surgical protocol 
Since the LDS is for a new concept of surgery, there were no 
specific guidelines for surgical protocols of laparoscopic RDN, 
such as ablation temperature or duration of treatment. To guide 
the ablation temperature in-vivo experiment, we used heat 
distribution results from in-vivo simulation. In addition, the 
duration of treatment was determined by cumulative equivalent 
minutes at 43℃ (CEM 43), which is a thermal dose unit used 
for determining damage threshold for a specific tissue [38, 39]. 
The CEM 43 is calculated using the equation (10):  
CEM 43 =  ∑ 𝑅(43−𝑇)∆𝑇,
𝑡=𝑓𝑖𝑛𝑎𝑙
𝑡=𝑜
 𝑅 = {
0.25,   𝑇 < 43 ℃
0.5,   𝑇 ≥ 43 ℃
 (10) 
where t is time (min), T is the temperature (℃) at time t, and R 
is a constant value. 
In this study, mid-line incision was performed with the swine 
in the supine position, and open surgery was performed to 
confirm the feasibility of the LDS. The Fig. 7 shows the 
timeline of the protocol in an animal study. After anesthesia, we 
inserted the catheter for BP monitoring and incised the bladder 
to drain the urine during the study. We ablated renal nerves 
bilaterally using LDS on a main, accessory, and branched 
arteries. The ablation duration was set to 70 seconds, which was 
based on the in vivo simulation results. The total maximum 
RDN procedure time was 20 min. After completing the surgery, 
renal arteries with nerves were harvested for 
immunohistochemical evaluation, and swine were euthanized. 
As a metric of effectiveness, we measured the acute change in 
BP after RDN. 
B. Swine model 
The performance of LDS and the ablation protocol were 
evaluated using a swine model. The swine is physiologically 
and anatomically similar to humans and are most commonly 
used in preclinical studies of cardiovascular devices [40].  
Seven swine of 45 kg each were NPO for 12 h and then were 
injected preoperatively with 0.06 mL/kg of Tardomyocel comp. 
III antibiotic. Sedation was induced by intramuscular 
application of zoletil (5 mg/kg) and xylazine (2 mg/kg). The 
preoxygenation using the facial mask and tracheal intubation 
was performed, and the depth of anesthesia was maintained 
under 2.0 to 2.5% of isoflurane with normoxia (SpO2 98%) and 
normocapnia (EtCO2 38-40 mmHg). Intravenous infusion of 
normal saline maintained central venous pressure between 6 
and 8 mmHg.  
C. Blood pressure acquisition and analysis 
 A sheath and catheter were inserted into the carotid artery, 
and the catheter nozzle was connected to a transducer for 
continuous monitoring of BP. The transducer was connected to 
a data acquisition system (iWorx RA-834 Recorder, iWorx 
Systems Inc) for further data processing, whose sampling rate 
is 100 sample/s. Anticoagulation was maintained with 
continuous intravenous bolus injection (40–50 IU/kg/h) of the 
unfractionated heparin. During the experiment, the depth of 
anesthesia was kept constant, and body surface ECG and pulse 
oximetry were monitored.  
To test the acute BP change due to RDN, we compared paired 
BP samples in a swine model, as shown in Fig. 7. After incising 
the bladder and finding the renal artery, we waited for BP to be 
stabilized before obtaining the baseline BP. The BP was 
expressed as the mean of arterial BP (MAP) and systolic BP 
(SBP) and was calculated at the last 2 minutes of steady-state. 
The BP after RDN was also acquired in a similar manner. We 
carried out a sham surgical control study except performing 
RDN. In the sham control study, the LDS procedure was 
stopped right after incising the bladder and the peritoneum near 
renal hilum. Care was taken not to damage any renal nerves 
located in the periarterial connective tissue. After BP was stable, 
we compared the initial BP (baseline) with the BP after 20 
minutes since the RND procedure took about 20 minutes. 
D. Immunohistochemical evaluation 
Each renal artery was fixed in 4% formalin for 24 hours, 
paraffin-embedded, and was then sectioned at 200 um intervals. 
For each section, 10 serial slides were cut with 4 um thickness. 
The quantitative analysis of protein denaturation and necrosis 
of renal sympathetic nerves around renal arteries was 
performed using hematoxylin and eosin (H&E) staining. The 
endothelial damage and smooth muscle fibrosis of renal arteries 
were assessed using Masson’s trichrome (MT) staining. 
E. Quantitative histological analysis 
Stained tissue slides were examined under digital pathology 
scanner (Aperio AT2, Leica) and were magnified 30, 200, and 
400 times by the pathology slide viewing software (Aperio 
ImageScope, Leica). We classified tissue slides into the control 
group and treatment group using 30 times magnification 
pictures. We labeled 71 nerves between those two groups and 
quantized the intensity and percent area fraction of the pixels 
that are the positive reaction for staining agents on 200 times 
magnification pictures. This was conducted on the image 
processing software (ImageJ software, National Institute of 
Health) [41-43]. The software calculated the mean intensity of 
the positive reaction area by averaging all RGB intensity within 
the region of interest of H&E stained image. The picture was 
separated via color decomposition as red, blue, and green when 
the positive reaction area was estimated. The area of blue in the 
deconvolution picture was calculated by adding all pixels over 
a specific threshold, which was decided by a previously 
reported iterative procedure based algorithm [44]. Finally, we 
calculated the change in the intensity and percent area fraction 
between non-ablation group and ablation group and found a 
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correlation between the change of staining and area of renal 
nerves. To quantify the characteristic of nerves, we used 
distance from the lumen (mm) and nerve size (um). The 
distance was the length from the center of each nerve to the 
nearest endoluminal surface. The nerves size was the radius 
calculated from the nerve area by assuming a perfect circle.    
F. Statistical analysis 
All statistical analyses were performed using the SPSS v25 
statistics tool (SPSS v25, IBM). All BP differences met the 
assumptions of normality and homogeneity of variance and 
were assessed by group t-test. All correlation analysis was 
performed by regression analysis.  
VI. RESULTS 
A. Thermal distribution of the bipolar flexible electrode 
Fig. 8a shows the heat distribution at x =0 and x = 3 planes in 
the FEM model of the parameter-controlling phantom gel after 
heating 90 seconds. The simulated peak temperature 
distribution in x = 3 plane is higher than the temperature in x = 
0 plane. The results confirm that the instrument could focus heat 
inside the instrument tip and between parallel electrodes. This 
simulation model was validated by comparing the simulated 
temperature profiles with experimental results at a total of 169 
points (13 points for each 13 section planes). As shown in Fig. 
6a, the temperature at the center of the tip is measured at 14 
points, 13 points are for fiber optic temperature probe, and the 
final point is for the thermocouple probe integrated within the 
instrument. The simulation and experimental results of 
normalized temperatures measured by the thermocouple probes 
in simulation and experiment are shown in Fig. 8b using scatter 
plots. The coefficient of determination in the scatter is 0.859, 
and the overall average error is 6.97%. The effect of the thermal 
conductivity from the sensitivity analyses shows that the peak 
temperature did not differ more than 1.2℃ between simulations 
and experimental methods, which is an acceptable difference. 
This good agreement between the simulation study and 
validation experiments confirmed the credibility of the 
simulation method and modeling. 
B. In vivo simulation and surgical protocol 
We utilized a numerical simulation model to evaluate the 
thermal distribution at the ablation tip of the artery 3D model. 
The model’s artery length, lumen diameter, the thickness of 
tunica media, and adventitia were set to 20 mm, 2 mm, 0.6 mm, 
and 0.9 mm respectively, with the blood flow rate set to 0.68 
m/s, as shown in Fig. 5. With the tip temperature maintained at 
65 ℃, the peak temperature distribution at the cross-section and 
the longitudinal section of the 3D artery model are shown in Fig. 
9. The heat is concentrated on the outside of the artery, in the 
cross-section, and between the parallel electrodes in the 
longitudinal section. The temperature profiles at the center of 
two parallel electrodes are shown in Fig. 10.  
We set 50 ℃ as an isothermal line, which is the thermal lesion 
boundary, or a nonviable volume [27]. Typically the renal 
 
Fig. 10. Two-dimensional temperature profiles with constant tip temperature 
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Fig. 11. Heat distribution in arteries with different sizes. (a) 2 x 0.5 x 1, (b) 2 
x 0.6 x 0.9, (c) 2 x 0.7 x 0.8, (d) 1.4 x 0.6 x 1.2, and (e) 2.6 x 0.6 x 0.6; lumen 
diameter (mm) x thickness of tunica media (mm) x thickness of tunica 
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Fig. 8. (a) Thermal distribution in the cross section of ablation tip in the FEM 
model of the phantom; at the side of the electrode (x=0 mm) and at the center 
of the electrode (x=3 mm). (b) Scatter plot of the temperature normalized by 
thermocouple probe showing the difference between the simulation and 
experimental results. (n=169, R2=0.859) 
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Fig. 9. (a) Thermal distribution at the cross section and (b) at the longitudinal 
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nerves distributed in tunica adventitia and periarterial 
connective tissue [20, 21]. Therefore, the ideal thermal lesion 
boundary should be located in the border between tunica media 
and adventitia while preventing thermal damage to tunica 
intima or lumen. Fig. 10 shows the border as a black dashed line 
at x = 1.6 mm. When the tip temperature remained at 60 ℃, the 
thermal lesion boundary was formed between tunica media and 
adventitia. As the tip temperature reached 65 ℃ , the lesion 
boundary extended to the tunica media. In addition, we 
evaluated the thermal distribution with arteries of different sizes 
when ablating at a constant tip temperature of 65 ℃, as shown 
in Fig. 11. With the diameter of lumen fixed at 2 mm, the 
thermal lesion boundaries were at 1.4 mm from the center of the 
artery for various of tunica media thickness, e.g., 0.5 mm, 0.6 
mm, and 0.7 mm. When the thickness of tunica media was fixed, 
and the diameter of the lumen was set at 1.4 mm and 2.6 mm, 
the thermal lesion boundaries were 1.2 mm and 1.6 mm, 
respectively, from the center of the artery. The electric 
potentials of an electrode in the simulation of Fig. 11(a-e) were 
20, 20.2, 20.3, 17.3, and 24.3 V. When the blood flow rate in 
the artery was varied, 0.28, 0.48 and 0.68 m/s, the thermal 
lesion boundaries were about 1.39 mm from the center of the 
artery, and the electrode electric potentials were 19.7, 19.9, and 
20.2 V, respectively. These results show that the ablation with 
a constant tip temperature generated the same heat distribution 
even when the blood flow rates were varied. Finally, from the 
simulation, we derived that the tip temperature should be 60 ℃ 
to 65 ℃   to completely ablate nerves while minimizing the 
damage on tunica intima.  
The duration of treatment was determined by CEM 43. When 
expressing the damage threshold as CEM 43, the damage 
threshold for the artery of the pig (150 min) is higher than the 
damage threshold for nerves of the pig (80 min) [38, 45]. If 
temperature T is maintained at 50 ℃   during treatment, we 
could derive the treatment duration as 70 s after considering the 
threshold as CEM 43 of the renal artery, where the thermal dose 
at nerves must be more than the threshold needed to ablate the 
nerve. Using this process, we used the numerical simulation 
technique to guide the animal study protocol such that the tip 
temperature was between 60 ℃  and 65 ℃  with an ablation 
duration of 70 s for safe and effective renal denervation. 
C. An animal study in a swine model 
The Fig. 12 shows a computed tomography angiography of the 
first swine artery. In this figure, the diameter of the left and the 
right renal arteries are about 2 to 5 mm, which are easily 
covered by our designed instrument tip. Fig. 13 shows the 
process of our designed flexible electrode, wrapping the renal 
artery. For 12 arteries belonging to five swine model, we 
performed RDN 21 times (see Table II). The RF system took 
7.14 s (±3.51) to reach 90% of pre-set tip temperature, called 
rising time, and percent maximum overshoot was 2.30 
(±1.98) %.  
 The histological assessment at 4 sites of the ablated artery, i.e., 
farthest site (control), distal site, proximal site, and ablation site 
(treatment), are shown in Fig. 14a. Fig. 14b compares the H&E 
staining results at the farthest site with those at the ablation site. 
Fig. 14c shows the results of histological analysis at each 
location. Columns; (1-n) the farthest site away from the ablation, 
control group; (2-n) the distal site from the ablation; (3-n) the 
proximal site from the ablation; (4-n) the ablation site, 
treatment group. Rows; (n-1) overall morphological 
characteristics of nerves and artery (x30, H&E); (n-2) the closer 
 
Fig. 13.  The process of electrosurgical instrument wrapping the renal artery 
TABLE II 
PERFORMANCE OF LDS IN ANIMAL STUDY 
Ablation # Animal # Target artery Artery type Position Temp. (℃) Rising time (s) 
Maximum 
overshoot (%) 
1 1 Left Main Proximal 60 2.59 2.28 
2 1 Left Main Distal 60 4.39 -0.69 
3 1 Right Main Proximal 65 4.33 -0.08 
4 1 Right Main Distal 65 12.61 1.78 
5 2 Left Main Proximal 65 14.99 1.60 
6 2 Left Main Distal 65 6.80 2.54 
7 2 Right Main Proximal 60 2.79 8.53 
8 2 Right Main Distal 65 10.79 -0.11 
9 2 Right Accessory - 65 7.00 4.79 
10 3 Left Branch Distal 60 5.20 3.75 
11 3 Left Branch Proximal 60 6.41 0.80 
12 3 Left Branch - 60 8.59 2.98 
13 3 Left Main - 60 3.79 0.52 
14 3 Right Main Distal 60 6.19 2.63 
15 3 Right Main Proximal 60 7.63 1.80 
16 4 Left Main Distal 60 5.60 3.22 
17 4 Left Main Proximal 60 7.80 2.67 
18 4 Right Main - 60 6.81 0.65 
19 5 Left Main - 60 6.61 2.83 
20 5 Right Main Distal 60 15.20 4.18 
21 5 Right Main Proximal 60 3.80 1.55 
 
 
Fig. 12.  Computed tomography (CT) angiography of a porcine 
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it is to the ablation site, the more noticeable denaturation of 
axons and neural fibers are, and the lower fiber density is (x200, 
H&E); (n-3) no arterial damage seen at any site (x30, MT). 
Arrows at 4-2 are hemorrhage. In the results of H&E staining, 
as shown in the first and second row of Fig. 14c, the closer the 
tissue is to the ablation site, the more noticeable denaturation of 
axons and neural fibers are and lower the fiber density is. The 
histology showed some hemorrhage at the ablation site inside 
nerves. On the other hand, no arterial damage is detected at any 
site, as shown in the third row of Fig. 14c, via MT staining. The 
arterial damage in the tunica intima is detected only in one of 
the 12 arteries at MT staining.  
Finally, BP is compared before and after RDN, as shown in 
Table III. There was an acute reduction in systolic blood 
pressure by 9.55 mmHg (p<0.001) and mean atrial pressure by 
8.23 mmHg (p<0.001). In the sham control study, BP increased 
over time (p<0.001). The results of quantitative histology 
analysis after the evaluation of 71 renal nerves are shown in Fig. 
11. Among the 71 nerves, the radius of 16 nerves (22.5%) were 
less than 50 um, 26 nerves (36.6%) were 50-100 um, 26 nerves 
(36.6%) were 100-200 um, and 3 nerves (4.2%) were over 200 
um. With respect to distance, all nerves were located within 2.5 
mm from the lumen. Comparing the control group and 
treatment group, the average difference in intensity and percent 
area fraction of positive reaction for H&E staining are 15.75 
(p<0.001) and 20.78 % (p<0.001), respectively. When 
compared between ablation temperature at 60 ℃ (n=48) and 65 ℃ 
(n=23), the difference in ablation is distinctly larger at 65 ℃ 
compared to 60 ℃, as shown in Fig. 11c, and d. The average 
difference between the two groups in intensity and in percent 
area fraction of positive reaction is 6.85 (p=0.031) and 8.42 
(p=0.025).  In Fig. 11e-h, the coefficients of determination in 
the scatter are 0.06 (p=0.521), 0.07 (p=0.474), 0.031 (p=0.143) 
and 0.106 (p=0.006) respectively, which showed the limited 
relationship exists between the reaction of staining and the 
nerve size or distribution.  
VII. DISCUSSION 
In this study, we presented a novel laparoscopic renal 
denervation system with a flexible electrode, which employs a 
direct nerve ablation technique by wrapping the renal artery. 
Our developed ablation instrument directly reaches the renal 
artery through retroperitoneal space and wraps both artery and 
nerves for effective nerve ablation at a constant ablation 
temperature. The flexible electrode can be utilized at various 
sizes of the artery and wraps all nerves independent of arterial 
anatomy and nerve distribution. During ablation, the electrode, 
which is composed of parallel bipolar electrodes, focuses on 
electrical current and heat distribution at the outer arterial wall 
for safe delivery of power. Furthermore, while the catheter-
based system cannot measure nerve temperature directly, our 
LDS can directly measure the temperature of the outer arterial 
wall with a temperature probe embedded inside the ablation tip, 
which helps further in achieving effective and safe renal 
denervation. We showed proof of the concept of LDS via 
computational modeling and animal study.  
The thermal distribution of the system was evaluated through 
both in vitro simulation and validation experiments. The good 
agreement between simulated and measured temperature 
 
Fig. 14.  Histological analysis of renal nerves and artery after RDN using LDS. (a) Histological assessment sections; 1. farthest site (control), 2. distal site, 3. 
proximal site, 4. ablation site (treatment). (b) Nerves stained with H&E at control and treatment section (x400). (c) Nerves and artery stained with H&E and MT 
at 1-4 sections. (H&E: hematoxylin and eosin, MT: masson’s trichrome) 
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suggests that the uniform and focused heat distribution around 
the surface of the arterial wall, as suggested by the 
computational model, can be expected in vivo. In vivo 
simulation, we designed a 3D model where the flexible 
electrode only wrapped renal artery avoiding a renal vein and 
lymph nodes, since the peripheral tissues can change the 
electrical current path and thermal distribution [46]. After 
filling CO2 gas into the abdomen and securing space to insert 
the laparoscopic instrument, as shown in Fig. 1b, the target 
renal artery begins to be detached from other tissues, as shown 
in Fig. 14a, and the flexible electrode will only wrap the artery. 
In this procedure, the tunica adventitia or connective tissue 
cannot be completely removed because of the risk of damaging 
the arteries. In addition, the exact ratio of the tunica media and 
adventitia thickness is difficult to determine. Thus, we analyzed 
the thermal distribution in arteries of different sizes using in-
vivo simulation. The ratio of tunica media and adventitia did not 
affect the thermal lesion boundaries, but the total thickness of 
the arterial wall did affect the boundary. Thus, based on the in 
vivo simulation results and CEM 43, we set the surgical 
protocol for safe and effective delivery as follows: constant tip 
temperature of 60 ℃ or 65 ℃ and an ablation duration of 70 s.  
Finally, we evaluated the preclinical applicability and safety 
of LDS. When the nerves in an animal study were compared 
between the treatment group and control group, the intensity 
and area fraction of positive reaction for histochemical were 
distinctly different. On the other hand, the arteries of these two 
groups were indistinguishable from each other and were 
confirmed via MT staining. The quantitative histology results 
showed that LDS will be able to damage all nerves regardless 
of nerve’s size and distance from the artery. The reanalysis 
results are along the lines of our expectation, showing more 
nerve damage at 65 ℃ when compared to 60 ℃, confirming the 
technique of the quantitative histology. Therefore, in an animal 
study using swine model, the flexible electrode could focus heat 
on the outer wall of the artery and effectively ablate renal nerves 
without arterial damage. Furthermore, since the depth of the 
thermal lesion does not increase in the constant-temperature 
ablation system, the duration of ablation can be adjusted to 
increase the thermal damage to the nerves [26]. Thus, while 
protecting the arterial walls of all types, LDS can completely 
damage all nerves by increasing the ablation duration. 
In our normotensive animal model, to exclude the effects of 
 
Fig. 15.  Change in (a) Intensity and (b) percent area fraction for H&E stained nerves in control and treatment group. (c) Change in intensity of positive reaction 
and (d) in percent area fraction for ablation temperature of 60 ℃ (n=48) and 65 ℃ (n=23). (e-h) Scatter plot between the nerve size or distance from lumen and 
the change in percent area fraction or in intensity. Statistical significance (a) p<0.001, (b) p<0.001, (c) p=0.031, (d) p=0.025, (e) p=0.521, (f) p=0.474, (g) p=0.143, 
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TABLE III 






Diff. (After – 
Baseline) 
Sham 1 SBP 103. 4(±1.  ) 10 . 6(±1. 6) 4.02* 
 MAP  3.54(±1.4 )   .35(±1.43) 3.81* 
Sham 2 SBP 75.54(±2.51) 79.57(±2.40) 4.03*  
 MAP 68.79(±2.24) 73.69(±2.13) 4.90* 
1 SBP  2.32(±3. 0) 6 .0 (±5.  ) -5.23*  
 MAP 62.2 (±2.  ) 5 .01(±4. 6) -3.25* 
2  SBP   . 5(±3.54) 6 .40(±4. 3) -9.55* 
 MAP 6 . 5(±2.6 ) 60. 1(±3. 4) -8.23* 
3 SBP 116.5 (±2.6 ) 116.40(±5.33) -0.51  (p=0.742) 
 MAP  6.  (±2.02)  6.  (±3.  ) -0.09  (p=0.806) 
4 SBP  5.05(±4.31)  6. 0(±4. 1) -8.25* 
 MAP  2.31(±3.4 ) 65.06(±3. 0) -7.25* 
5 SBP  3.04(±2.06)   .14(±2.13) -3.90* 
 MAP  3. 5(±1.6 ) 6 .54(±1. 3) -4.23* 
*P < 0.001 
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the drop in blood pressure by general anesthesia, sedation, 
drugs, or RDN procedures, the depth of anesthesia was 
approximately maintained throughout the operation. The renal 
denervation took approximately 20 minutes, and BP was 
measured after completing the renal denervation and achieving 
a stable state. We detected an acute decrease in BP after renal 
denervation, while the sham control study showed no 
meaningful change in BP. In the laparoscopic RDN procedure, 
the nerves at periarterial connective tissue (Fig. 1(b2)) were 
removed surgically, and those at tunica adventitia were 
damaged by LDS. Based on results from our study and 
previously published results [47, 48], we expect that the nerves 
located at and beyond 2.5 mm from lumen would be removed 
surgically and the remaining nerve would be denervated by 
LDS. From the literature, as described in [46, 49], the renal 
nerve damage increases the reduction in BP. Furthermore, 
sympathectomy, which completely destroys sympathetic nerves, 
also has shown to reduce BP immediately after the procedure 
and has shown to maintain the reduction [50]. Thus, we expect, 
the effective nerve damage by LDS combined with laparoscopy 
would induce an acute decrease in BP and would result in a 
cascaded BP decrease thereafter. 
From the viewpoint of the IDEAL (Idea, Development, 
Exploration, Assessment, and Long-term monitoring) 
framework proposed by P. McCulloch et al.[51], our study 
using LDS is a proof of concept idea and preclinical 
development for the pathway to technical refinement, stability, 
and assurance [52]. Through LDS, we expect to provide a 
solution for controlling lethal resistant hypertension by creating 
a standardized procedure that is safe and yields possibly similar 
results between experienced operators and novices. In addition, 
the system is flexible and adaptable and thus can accommodate 
renal sympathetic nerves plexus of various sizes. Since the 
system has the ability to accesses sympathetic nerve directly, it 
can treat sympathetic nerves located in any proximity of renal 
artery, e.g., nerves located far from the lumen in the proximal 
segment of a renal artery, nerves located close to the arterial 
wall, and nerves inside tunica adventitia of artery [21]. The 
previous approach, such as the catheter-based RDN, does not 
have such flexibility and were of limited use. Our LDS 
approach is innovative, inventive, and opens up the novel 
opportunity for hypertension treatment. In addition, our 
proposed system can be expanded to other therapeutic modality 
as well for treating autonomic nervous system disorders.  
VIII. CONCLUSION AND FUTURE WORK 
Through mathematical model and simulator study, we 
established the proof of concept of the novel laparoscopy-based 
renal denervation system, which employs a direct nerve 
ablation technique with automated temperature control and 
flexible electrode to denervate nerves around any artery size. 
The simulation study using LDS showed that the heat focused 
on the outer arterial wall while maintaining a constant tip 
temperature of 65 ℃ for 70 s is a suitable treatment protocol. In 
the acute swine model study, renal denervation was achieved 
regardless of nerve size and distribution, resulting in an acute 
reduction in blood pressure while preventing arterial damage. 
Our technology developed and our methodology adopted are 
sufficient to prove the validity of such an approach, which can 
be explored further for other applications in addition to 
hypertension treatment. 
This paper focused mainly on demonstrating the feasibility of 
the proposed novel technology through the mathematic model 
and in vivo study. We performed laparoscopic renal 
denervation on the acute swine model and in an open surgery 
setting to show the effectiveness of the system in vivo. For 
verifying the efficiency of controlling BP and the safety of the 
laparoscopic denervation system in vivo, further animal studies 
are needed. As a next step, we plan to conduct animal studies 
using a survival swine model with the laparoscopic procedure 
to verify the lowering of BP, neurotransmitter level, and to 
evaluate whether arterial stenosis by arterial damage is detected 
after the treatment using the LDS system. 
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